BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1036828)

  • 1. Analysis of the disappearance curve of labelled fibrinogen at the time of hyperfibrinogenemia in rabbits with acute or chronic intravascular coagulation.
    Hasegawa H; Watanabe N; Nagata H; Murao M
    Thromb Haemost; 1976 Aug; 36(1):49-59. PubMed ID: 1036828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen survival and fibrinopeptide A in acute leukemia.
    Castaman G; Galloni E; Dri AV; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):52-6. PubMed ID: 8039760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on catabolism of 125I-labelled fibrinogen in normal rabbits and in rabbits with indwelling intravenous catheters: methodologic aspects.
    Mahn I; Müller-Berghaus G
    Haemostasis; 1975; 4(1):41-50. PubMed ID: 1193455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Letter: The half-life of labelled fibrinogen during acute diseases].
    Larcan A; Robert J; Lambert H; Hennequin G; Mabille H
    Nouv Presse Med; 1976 Feb; 5(9):587. PubMed ID: 1264728
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of obstetrical disseminated intravascular coagulation--sequential changes of coagulation and fibrinolytic system in DIC rabbits].
    Saito H
    Nihon Sanka Fujinka Gakkai Zasshi; 1983 Apr; 35(4):507-16. PubMed ID: 6189925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of factor Xa/phospholipid infusion on the acute phase response in baboons.
    Kruithof EK; Agay D; Mestries JC; Gascon MP; Ythier A
    Thromb Haemost; 1997 Feb; 77(2):308-11. PubMed ID: 9157587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depletion of plasma factor XIII prevents disseminated intravascular coagulation-induced organ damage.
    Lee SY; Chang SK; Lee IH; Kim YM; Chung SI
    Thromb Haemost; 2001 Mar; 85(3):464-9. PubMed ID: 11307816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of soluble fibrin in evaluating the acute and chronic hypercoagulable state.
    Dempfle CE
    Thromb Haemost; 1999 Aug; 82(2):673-83. PubMed ID: 10605767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Determination of the rate of microthrombosis in experimentally induced disseminated intravascular coagulation (DIC)].
    Nowak G; Hoffmann J; Markwardt F
    Acta Biol Med Ger; 1976; 35(11):K63-K68. PubMed ID: 1022125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of infusion of thrombin or endotoxin in rabbits treated with cortisone.
    Stafford BT; Rapaport SI; Shen SM
    Thromb Diath Haemorrh; 1975 Sep; 34(1):159-68. PubMed ID: 1188709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of two-domain tissue factor pathway inhibitor on endotoxin-induced disseminated intravascular coagulation in rabbits.
    Bregengård C; Nordfang O; Wildgoose P; Svendsen O; Hedner U; Diness V
    Blood Coagul Fibrinolysis; 1993 Oct; 4(5):699-706. PubMed ID: 8292719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparin-enhanced inhibitors during reversible disseminated intravascular coagulation.
    Marbet GA; Griffith MJ; Roberts HR
    Scand J Clin Lab Invest Suppl; 1985; 178():95-8. PubMed ID: 3867125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulant properties of rabbit lungs in tissue thromboplastin-induced intravascular coagulation.
    Vad H; Tvedskov TF; Hansen KB; Albrechtsen OK; Jespersen J; Gram J
    Thromb Haemost; 1997 Apr; 77(4):679-84. PubMed ID: 9134642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute polycythemia increases the disappearance rate of clottable fibrinogen in the newborn dog.
    LeBlanc MH; Edwards JD
    Pediatr Res; 1986 Feb; 20(2):151-4. PubMed ID: 3945524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intravascular coagulation: symptom or disease?].
    Straub PW
    Schweiz Med Wochenschr; 1979 Sep; 109(37):1351-6. PubMed ID: 482906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of fibrinopeptide A as an indicator for coagulative analysis in thrombotic diseases].
    Murakoshi T
    Hokkaido Igaku Zasshi; 1982 May; 57(3):351-63. PubMed ID: 6957368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disseminated intravascular coagulation in the early phase of experimental traumatic and haemorrhagic shock.
    Avikainen V; Eklund B
    Ann Chir Gynaecol Fenn; 1974; 63(3):217-25. PubMed ID: 4412844
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats.
    Yamazaki M; Asakura H; Aoshima K; Saito M; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Ikeda T; Matsuda T
    Thromb Haemost; 1994 Sep; 72(3):392-6. PubMed ID: 7855790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombin elaboration in endotoxin-induced intravascular fibrin deposition. A leukocyte dependent process distinct from systemic hypercoagulability.
    Lipinski B; Gurewich V; Hyde E
    Thromb Haemost; 1976 Dec; 36(3):615-22. PubMed ID: 1037155
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute von Willebrand factor secretion from the endothelium in vivo: assessment through plasma propeptide (vWf:AgII) Levels.
    Vischer UM; Ingerslev J; Wollheim CB; Mestries JC; Tsakiris DA; Haefeli WE; Kruithof EK
    Thromb Haemost; 1997 Feb; 77(2):387-93. PubMed ID: 9157601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.